Consistent with the in vitro findings, suppressing both AMPK and FOXO3 in SIRT1-overexpressing xenograft tumors substantially reversed the improved cisplatin sensitivity, as indicated by the tumor volumes and TUNEL staining (Fig. 4d–f). This evidence concerns the gene FOXO3 and neoplasm.